GlassScriptPhysician profile
Michael S Flood
NPI 1346247715
$54,348.63
in general payments reported to CMS, 2019-2025
12 companies · $2,917 in 2025
The $2,917 reported for 2025 was more than what 89% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $12K · 2021: $6,793 · 2022: $4,650 · 2023: $2,645 · 2024: $8,048 · 2025: $2,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,250 · Travel and Lodging: $4,615 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,250.00 |
| Travel and Lodging | $4,614.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Food and Beverage | $1,495.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $34,838.96 | 2019-2021 | |
| Lifenet Health | $7,918.29 | 2023-2024 | Theragenesis Wound Matrix |
| Bioventus LLC | $7,067.01 | 2022-2023 | |
| Smith+Nephew, INC. | $3,144.64 | 2019-2025 | Pico, Collagenase Santyl, Grafix |
| Kci USA, INC. | $735.22 | 2019 | |
| Tactile Systems Technology INC | $213.63 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Siemens Medical Solutions USA, INC. | $160.14 | 2024 | Biograph Mct X-4r |
| Organogenesis INC. | $137.12 | 2019 | |
| Cashflow Solutions, LLC | $73.57 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Acell, INC. | $23.27 | 2020 | |
| Solventum Corporation | $20.74 | 2024 | Activ.A.C. |
| Integra Lifesciences Corporation | $16.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Flood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.